MillBridge Pharmaceutical Science was established at the end of
2004 when Ken Caldicott decided to leave the industrial sector in order
to enjoy the freedom of consultancy.
Ken had worked in several pharmaceutical companies including the
Parke-Davis Research division of Warner Lambert and Penn Pharmaceutical
Services. He held a variety of roles in analytical chemistry,
formulation, Quality Assurance and management culminating in the
position of Chief Scientific Officer at Penn. In this latter role
he was able to combine more than thirty years pharmaceutical
development and quality experience and use this to provide strategic
support and regulatory guidance to a range of international
pharmaceutical companies of various sizes from virtual to medium size
pharma. Whilst in this position he has written, or contributed
to, a considerable number of CMC / Quality sections of regulatory
submissions, particularly for clinical trials applications.
Ken has considerable international experience having worked with, and
audited, facilities throughout the EU, US, Canada, Brazil, Taiwan,
Japan, Egypt and South Korea. He has also presented at
conferences and seminars in the UK, US and Japan.
Ken's academic and professional qualifications are:-
PhD in analytical chemistry and chemometrics
Chartered Chemist
Fellow of the Royal Society of Chemistry